A detailed history of Cherrydale Wealth Management, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Cherrydale Wealth Management, LLC holds 1,513 shares of ABT stock, worth $198,777. This represents 0.06% of its overall portfolio holdings.

Number of Shares
1,513
Previous 1,599 5.38%
Holding current value
$198,777
Previous $217,000 6.91%
% of portfolio
0.06%
Previous 0.08%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 14, 2025

SELL
$120.51 - $136.62 $10,363 - $11,749
-86 Reduced 5.38%
1,513 $202,000
Q2 2025

Jul 14, 2025

BUY
$123.95 - $138.08 $10,535 - $11,736
85 Added 5.61%
1,599 $217,000
Q1 2025

Apr 14, 2025

BUY
$111.1 - $140.22 $168,205 - $212,293
1,514 New
1,514 $200,000
Q2 2024

Jul 11, 2024

BUY
$100.73 - $112.44 $197,934 - $220,944
1,965 New
1,965 $204,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $230B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Cherrydale Wealth Management, LLC Portfolio

Follow Cherrydale Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cherrydale Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cherrydale Wealth Management, LLC with notifications on news.